Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients

NCT05703971 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer Extensive Stage

Interventions

BIOLOGICAL: quaratusugene ozeplasmid
BIOLOGICAL: atezolizumab

Sponsor

Genprex, Inc.